No overview information available.
No background information available.
No indication information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|---|---|---|---|---|
ORAL | 4 [hp_X] in 1 1 | 2025/04/09 | 54973-3257 | ||
ORAL | 10 [hp_X] in 59 mL | 2025/05/19 | 57955-9003 | ||
ORAL | 10 [hp_X] in 59 mL | 2025/05/19 | 57955-9005 | ||
ORAL | 10 [hp_X] in 59 mL | 2025/05/19 | 57955-9004 | ||
ORAL | 10 [hp_X] in 59 mL | 2025/05/19 | 57955-5638 |
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|
No NMPA products found for this drug
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|---|---|---|---|---|
343666 | Active | 2020/09/17 | Passiflora incarnata | ||
313001 | Active | 2019/01/08 | Passiflora incarnata | ||
356361 | Active | 2021/03/09 | Passiflora incarnata | ||
426790 | Active | 2023/10/24 | Passiflora incarnata | ||
409292 | Active | 2023/05/22 | Passiflora incarnata | ||
188865 | Active | 2011/09/05 | Passiflora incarnata | ||
391881 | Active | 2022/07/06 | Passiflora incarnata | ||
488665 | Active | 2025/05/13 | Passiflora incarnata | ||
485385 | Active | 2025/04/07 | Passiflora incarnata | ||
489563 | Active | 2025/05/22 | Passiflora incarnata |